Valeo Pharma Inc T.VPH

Alternate Symbol(s): T.VPH.DB | VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

TSX:VPH - Post by User

Valeo Pharma Inc > On track and looking good - added more yesterday

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on May 08, 2021 12:23pm

130 Views

Post# 33159894

RE:RE:RE: On track and looking good - added more yesterday

LaurinDE wrote: low trading volume is an invitation to "play" with the stock. As soon as the company releases data that confirms the revenues they promise, there will be serious buying interest and then the share will appreciate very quickly, imo.
L

I am banking on it. Fully loaded. this stagflation is mind boggling considering the share float. Insiders own 65% and don't seem to be interested in moving the share price. I suspect if we get good solid revenues in Q2-21 ( by the end of June) then we will see a substantial rise in SP. I hope they don't wait too long as the markets are getting long in the tooth and a correction is inevitable at some point.

<< Previous

Bullboard Posts

Next >>

ATCO pursues regulatory approval for $2.8B Alberta pipeline